EFFICACY, SAFETY AND TOLERABILITY OF RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS INFUSION OF IMMUNOGLOBULIN G IN ADULT PATIENTS WITH PRIMARY IMMUNODEFICIENCIES: PHASE 3 STUDY RESULTS

被引：0

作者：

Stein, Mark ^{[1
]}

Wasserman, Richard L. ^{[2
]}

Melamed, Isaac ^{[3
]}

Rubinstein, Arye ^{[4
,5
]}

Puck, Jennifer ^{[6
]}

Gupta, Sudhir ^{[7
]}

Engl, Werner ^{[8
]}

Leibl, Heinz ^{[8
]}

McCoy, Barbara ^{[8
]}

Yel, Leman ^{[9
]}

Schiff, Richard I. ^{[9
]}

机构：

[1] Allergy Associates Palm Beaches, North Palm Beach, FL USA

[2] DallasAllergyImmunol, Dallas, TX USA

[3] IMMUNOe Hlth Ctr, Centennial, CO USA

[4] Albert Einstein Coll Med, Bronx, NY 10467 USA

[5] Montefiore Hosp, Bronx, NY USA

[6] Univ Calif San Francisco, San Francisco, CA 94143 USA

[7] Univ Calif Irvine, Irvine, CA USA

[8] Baxter BioSci, Vienna, Austria

[9] Baxter BioSci, Westlake Village, CA USA

来源：

JOURNAL OF CLINICAL IMMUNOLOGY | 2014年 / 34卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：727 / 727

页数：1

共 50 条

[1] LONG-TERM SAFETY, EFFICACY, AND TOLERABILITY OF RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS INFUSION OF IMMUNOGLOBULIN G IN PATIENTS AGED ≥16 YEARS WITH PRIMARY IMMUNODEFICIENCIES
Wasserman, R. L.
Stein, M.
Kobrynski, L.
Gupta, S.
Grant, J.
Rubinstein, A.
Engl, W.
McCoy, B.
Leibl, H.
Yel, L.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A103 - A103
[2] Efficacy, Safety and Tolerability of Recombinant Human Hyaluronidase (RHUPH20)-Facilitated Subcutaneous (SC) Infusion of Immunoglobulin G (IGSC) (IGHY) in Adult Patients with Primary Immunodeficiencies (PI): Phase 3 Study Results
Stein, Mark R.
Wasserman, Richard L.
Melamed, Isaac
Rubinstein, Arye
Puck, Jennifer
Gupta, Sudhir
Engl, Werner
Leibl, Heinz
McCoy, Barbara
Yel, Leman
Schiff, Richard I.
JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (03) : 380 - 381
[3] Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency
Wasserman, Richard L.
Melamed, Isaac
Stein, Mark R.
Engl, Werner
Sharkhawy, Marlies
Leibl, Heinz
Puck, Jennifer
Rubinstein, Arye
Kobrynski, Lisa
Gupta, Sudhir
Grant, Andrew J.
Ratnayake, Anoshie
Richmond, Wendell G.
Church, Joseph
Yel, Leman
Gelmont, David
JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (06) : 571 - 582
[4] Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency
Richard L. Wasserman
Isaac Melamed
Mark R. Stein
Werner Engl
Marlies Sharkhawy
Heinz Leibl
Jennifer Puck
Arye Rubinstein
Lisa Kobrynski
Sudhir Gupta
Andrew J. Grant
Anoshie Ratnayake
Wendell G. Richmond
Joseph Church
Leman Yel
David Gelmont
Journal of Clinical Immunology, 2016, 36 : 571 - 582
[5] Tolerability and safety of recombinant human hyaluronidase-facilitated subcutaneous infusion of human immune globulin G, 10%, in patients with primary immunodeficiencies: A study from North America
Kobayashi, R.
Stein, M.
Darter, A.
Gupta, S.
Engl, W.
Leibl, H.
Fielhauer, K.
Schiff, R. I.
ALLERGY AND ASTHMA PROCEEDINGS, 2013, 34 (03) : 298 - 298
[6] TOLERABILITY AND SAFETY OF RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS INFUSION OF HUMAN IMMUNE GLOBULIN G, 10%, IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES: A STUDY FROM NORTH AMERICA
Kobayashi, R.
Stein, M. R.
Darter, A.
Paris, K.
Gupta, S.
Testori, A.
Engl, W.
Leibl, H.
Filhauer, K.
Schiff, R. I.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (05) : A98 - A98
[7] Overview of recombinant human hyaluronidase-facilitated subcutaneous infusion of IgG in primary immunodeficiencies
Wasserman, Richard L.
IMMUNOTHERAPY, 2014, 6 (05) : 553 - 567
[8] LONG-TERM TOLERABILITY AND SAFETY OF FACILITATED-SUBCUTANEOUS INFUSION OF HUMAN IMMUNOGLOBULIN G, 10%, AND RECOMBINANT HUMAN HYALURONIDASE: A PHASE 3 EXTENSION STUDY IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES
Melamed, Isaac
Wasserman, Richard L.
Stein, Mark
Rubinstein, Arye
Puck, Jennifer
Gupta, Sudhir
Engl, Werner
Leibl, Heinz
Yel, Leman
Schiff, Richard I.
JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (06) : 727 - 728
[9] TOLERABILITY AND EFFICACY OF FACILITATED-SUBCUTANEOUS INFUSION OF HUMAN IMMUNOGLOBULIN G, 10%, AND RECOMBINANT HUMAN HYALURONIDASE (IGHY): SUBSET OF STUDY PATIENTS WITH PRIMARY IMMUNODEFICIENCIES (PI)
Wasserman, R. L.
Melamed, I.
Stein, M.
Puck, J.
Gupta, S.
Engl, W.
Leibl, H.
Gelmont, D.
Schiff, R. I.
JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 155 - 156
[10] Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin infusion in primary immunodeficiency diseases
Wasserman, Richard L.
IMMUNOTHERAPY, 2017, 9 (12) : 1035 - 1050

← 1 2 3 4 5 →